Paying users zone. Data is covered by 
.
Get to Bristol-Myers Squibb Co. for $15.99, or
get to whole website for at least 3 months from $49.99.
Price to Earnings (P/E)
since 2005
Difficulty: Beginner
Calculation
Bristol-Myers Squibb Co., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net earnings attributable to BMS1 (in millions) |
÷ | No. shares of common stock outstanding2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2005 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2006 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2007 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2008 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2009 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2010 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2011 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2012 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2013 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2014 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2015 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2016 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2017 | |
= | |
÷ | |
|
= | |
÷ | |
1 USD $
2 Data adjusted for splits and stock dividends.
3 Close price on the filing date of Bristol-Myers Squibb Co.'s Annual Report.
Source: Based on data from Bristol-Myers Squibb Co. Annual Reports
Comparison to Competitors
Bristol-Myers Squibb Co., P/E, long-term trends, comparison to competitors
| Bristol-Myers Squibb Co. | Abbott Laboratories | AbbVie Inc. | Allergan PLC | Amgen Inc. | Biogen Inc. | Celgene Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2005 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2006 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2007 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2008 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2009 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2010 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2011 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2012 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2013 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2014 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2015 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2016 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2017 | |
|
|
|
|
|
|
|
|
|
|
|
|
Source: Based on data from Bristol-Myers Squibb Co. Annual Reports
Comparison to Pharmaceuticals & Biotechnology Sector
Bristol-Myers Squibb Co., P/E, long-term trends, comparison to Pharmaceuticals & Biotechnology sector
| Bristol-Myers Squibb Co. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2005 | |
|
| Dec 31, 2006 | |
|
| Dec 31, 2007 | |
|
| Dec 31, 2008 | |
|
| Dec 31, 2009 | |
|
| Dec 31, 2010 | |
|
| Dec 31, 2011 | |
|
| Dec 31, 2012 | |
|
| Dec 31, 2013 | |
|
| Dec 31, 2014 | |
|
| Dec 31, 2015 | |
|
| Dec 31, 2016 | |
|
| Dec 31, 2017 | |
|
Source: Based on data from Bristol-Myers Squibb Co. Annual Reports
Comparison to Health Care Industry
Bristol-Myers Squibb Co., P/E, long-term trends, comparison to Health Care industry
| Bristol-Myers Squibb Co. | Health Care | |
|---|---|---|
| Dec 31, 2005 | |
|
| Dec 31, 2006 | |
|
| Dec 31, 2007 | |
|
| Dec 31, 2008 | |
|
| Dec 31, 2009 | |
|
| Dec 31, 2010 | |
|
| Dec 31, 2011 | |
|
| Dec 31, 2012 | |
|
| Dec 31, 2013 | |
|
| Dec 31, 2014 | |
|
| Dec 31, 2015 | |
|
| Dec 31, 2016 | |
|
| Dec 31, 2017 | |
|
Source: Based on data from Bristol-Myers Squibb Co. Annual Reports
